Seniors

UPDATE-Annual Veterans Day Commemoration Held at Bronx Victory Memorial

By SÍLE MOLONEY
Bronx Community Board 7 (CB7) members were joined by veterans, residents of the district, Bedford Mosholu Community Association (BMCA) members, members of the 52nd Precinct Community Council and others for their 2nd Annual Veterans Day Commemoration held at the Bronx Victory Memorial on Mosholu Parkway in Bedford Park to mark Veterans Day.

Local Artist Barbara Korman Fondly Remembered

By SÍLE MOLONEY & DAVID GREENE
Renowned Bedford Park artist Barbara Korman has been remembered fondly by those who knew her following her recent death on Thursday, Nov. 30, at the age of 85. Bedford Mosholu Community Association president Barbara Stronczer, who said Korman was buried on Sunday, Dec. 3, said of her friend, “Barbara was a talented individual with many interests. She will be missed by both friends and neighbors.”

UPDATE Edenwald Man Shot Dead by Police after Apparent Multiple Stabbing of Family Members in Queens Home

By SÍLE MOLONEY
Five family members have died, including one deceased perpetrator who police say is from the Edenwald section of The Bronx and is a cousin to some of the family members, following a multiple stabbing incident, residential fire, and police shooting in the Far Rockaway section of Queens in the early hours of Sunday morning, Dec. 3. Two police officers and another family member were also injured in the incident.

UPDATE FDNY Called to Tracey Towers for Compactor Fire

By SÍLE MOLONEY
A compactor fire at Tracey Towers, the twin-tower, Mitchel Lama, residential housing complex located on the Bedford Park/Norwood border, on Saturday, Nov. 25, resulted in no injuries, according to the FDNY.

Montefiore Einstein Awarded FDA Grant for Clinical Trial on Experimental Blood Cancer Treatment

By SÍLE MOLONEY
Two related blood cancers that disproportionally target older adults called acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), are notoriously difficult to treat and are associated with high relapse rates, according to medical experts at Montefiore Einstein Comprehensive Cancer Center (MECCC). Although new therapies have improved survival rates, they say treatment options remain limited, and the prognosis for the 50% of people who have these cancers, remains poor.